The DOI matches its OpenAlex record; 49 of the 49 references it cites were found in a registry or an index.
Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
Abstract
PURPOSE: Insulin, a member of a family of growth factors that includes insulin-like growth factor (IGF)-I and IGF-II, exerts mitogenic effects on normal and malignant breast epithelial cells, acting via insulin and IGF-I receptors. Because of this and because of its recognized association with obesity, an adverse prognostic factor in breast cancer, we examined the prognostic associations of insulin in early-stage breast cancer. PATIENTS AND METHODS: A cohort of 512 women without known diabetes, who had early-stage (T1 to T3, N0 to N1, and M0) breast cancer, was assembled and observed prospectively. Information on traditional prognostic factors and body size was collected, and fasting blood was obtained. RESULTS: Fasting insulin was associated with distant recurrence and death; the hazard ratios and 95% confidence intervals (CI) for those in the highest (> 51.9 pmol/L) versus the lowest (< 27.0 pmol/L) insulin quartile were 2.0 (95% CI, 1.2 to 3.3) and 3.1 (95% CI, 1.7 to 5.7), respectively. There was some evidence to suggest that the association of insulin with breast cancer outcomes may be nonlinear. Insulin was correlated with body mass index (Spearman r = 0.59, P <.001), which, in turn, was associated with distant recurrence and death (P <.001). In multivariate analyses that included fasting insulin and available tumor- and treatment-related variables, adjusted hazard ratios for the upper versus lower insulin quartile were 2.1 (95% CI, 1.2 to 3.6) and 3.3 (95% CI, 1.5 to 7.0) for distant recurrence and death, respectively. CONCLUSION: Fasting insulin level is associated with outcome in women with early breast cancer. High levels of fasting insulin identify women with poor outcomes in whom more effective treatment strategies should be explored.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Impact of Event Scale: A Measure of Subjective Stress
Horowitz, M., Wilner, N., & Alvarez, W. (1979) · Psychosomatic Medicine · doi:10.1097/00006842-197905000-00004 · Cited by 7,813
Body-Mass Index and Mortality in a Prospective Cohort of U.S. Adults
Calle, E. E., Thun, M. J., Petrelli, J. M., Rodriguez, C., & Heath, C. W. (1999) · New England Journal of Medicine · doi:10.1056/nejm199910073411501 · Cited by 3,643
A DATA-BASED APPROACH TO DIET QUESTIONNAIRE DESIGN AND TESTING
BLOCK, G., HARTMAN, A. M., DRESSER, C. M., CARROLL, M. D., GANNON, J., & GARDNER, L. (1986) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114416 · Cited by 2,163
Circulating concentrations of insulin-like growth factor I and risk of breast cancer
Hankinson, S. E., Willett, W. C., Colditz, G. A., Hunter, D. J., Michaud, D. S., Deroo, B., Rosner, B., Speizer, F. E., & Pollak, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)10384-1 · Cited by 1,823
Combination Chemotherapy as an Adjuvant Treatment in Operable Breast Cancer
Bonadonna, G., Brusamolino, E., Valagussa, P., Rossi, A., Brugnatelli, L., Brambilla, C., De Lena, M., Tancini, G., Bajetta, E., Musumeci, R., et al. (1976) · New England Journal of Medicine · doi:10.1056/nejm197602192940801 · Cited by 1,329
Frasca, F., Pandini, G., Scalia, P., Sciacca, L., Mineo, R., Costantino, A., Goldfine, I. D., Belfiore, A., & Vigneri, R. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3278 · Cited by 902
Le Roith, D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199702273360907 · Cited by 897
Levine, M. N., Bramwell, V. H., Pritchard, K. I., Norris, B. D., Shepherd, L. E., Abu-Zahra, H., Findlay, B., Warr, D., Bowman, D., Myles, J., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2651 · Cited by 617
Self-citationInsulin resistance and breast‐cancer risk
Bruning, P. F., Bonfrèr, J. M. G., van Noord, P. A. H., Hart, A. A. M., de Jong‐Bakker, M., & Nooijen, W. J. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520402 · Cited by 361
Insulin and related factors in premenopausal breast cancer risk
Del Giudice, M. E., Fantus, I. G., Ezzat, S., McKeown-Eyssen, G., Page, D., & Goodwin, P. J. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1005831013718 · Cited by 304
Self-citationSignificance of Axillary Lymph Node Metastasis in Primary Breast Cancer
Jatoi, I., Hilsenbeck, S. G., Clark, G. M., & Osborne, C. K. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.8.2334 · Cited by 299
Camoriano, J. K., Loprinzi, C. L., Ingle, J. N., Therneau, T. M., Krook, J. E., & Veeder, M. H. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.8.1327 · Cited by 291
Fisher, B., Redmond, C., Legault-Poisson, S., Dimitrov, N. V., Brown, A. M., Wickerham, D. L., Wolmark, N., Margolese, R. G., Bowman, D., & Glass, A. G. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.6.1005 · Cited by 291
Papa, V., Gliozzo, B., Gm, C., McGuire, W. L., Moore, D. H., Fujita‐Yamaguchi, Y., Vigneri, R., Goldfine, I. D., & PEZZINO, V. (1993) · PubMed · Cited by 276
Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer
Peyrat, J. P., Louchez, M. M., Lefebvre, J., Bonneterre, J., Vennin, P., Demaille, A., Helquet, B., & Fournier, C. (1993) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80137-6 · Cited by 273
Pandini, G., Vigneri, R., Costantino, A., Frasca, F., Ippolito, A. M., Fujita‐Yamaguchi, Y., Siddle, K., Goldfine, I. D., & Belfiore, A. (1999) · PubMed · Cited by 255
Zhang, S., Folsom, A. R., Sellers, T. A., Kushi, L. H., & Potter, J. D. (1995) · Cancer · doi:10.1002/1097-0142(19950715)76:2<275::aid-cncr2820760218>3.0.co;2-6 · Cited by 201
Socioeconomic Factors and Race in Breast Cancer Recurrence and Survival
Gordon, N. H., Crowe, J. P., Brumberg, J., & Berger, N. A. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116340 · Cited by 189
Obesity at Diagnosis of Breast Carcinoma Influences Duration of Disease-free Survival
Senie, R. T., Rosen, P. P., Rhodes, P., Lesser, M. L., & Kinne, D. W. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-26 · Cited by 180
Rosner, G. L., Hargis, J. B., Hollis, D. R., Budman, D. R., Weiss, R. B., Henderson, I. C., & Schilsky, R. L. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.11.3000 · Cited by 178
Jackson, J. G., White, M. F., & Yee, D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9994 · Cited by 171
Bastarrachea, J., Hortobagyi, G. N., Smith, T. L., Kau, S.-W. C., & Buzdar, A. U. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-1-199401010-00004 · Cited by 171
Body size and breast cancer prognosis: A critical review of the evidence
Goodwin, P. J., & Boyd, N. F. (1990) · Breast Cancer Research and Treatment · doi:10.1007/bf01806329 · Cited by 152
Self-citationPrognostic significance of insulin-like growth factor 1 receptors in human breast cancer.
Bonneterre, J. M., Peyrat, J. P., Beuscart, R., et al. (1990) · PubMed · Cited by 136
Race, Nutritional Status, and Survival From Breast Cancer
Coates, R. J., Clark, W. S., Eley, J. W., Greenberg, R. S., Huguly, C. M., & Brown, R. L. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.21.1684 · Cited by 117
Insulin receptors in breast cancer: Biological and clinical role
Papa, V., & Belfiore, A. (1996) · Journal of Endocrinological Investigation · doi:10.1007/bf03347871 · Cited by 116
The effect of pre-morbid height and weight on the survival of breast cancer patients
Tretli, S., Haldorsen, T., & Ottestad, L. (1990) · British Journal of Cancer · doi:10.1038/bjc.1990.282 · Cited by 115
Vadgama, J. V., Wu, Y., Datta, G. D., Khan, H. M., & Chillar, R. K. (1999) · Oncology · doi:10.1159/000012052 · Cited by 105
Railo, M. J., von Smitten, K., & Pekonen, F. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90247-x · Cited by 103
Insulin receptor expression and clinical outcome in node-negative breast cancer.
Mathieu, M. C., Clark, G. M., Allred, D. C., Goldfine, I. D., & Vigneri, R. (1997) · PubMed · Cited by 91
Zhang, X., & Yee, D. (2000) · Breast Cancer Research · doi:10.1186/bcr50 · Cited by 84
Survival of breast‐cancer patients and body size indicators
Kyogoku, S., Hirohata, T., Takeshita, S., et al. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910460513 · Cited by 74
Maehle, B. O., & Tretli, S. (1996) · Breast Cancer Research and Treatment · doi:10.1007/bf01807157 · Cited by 72
The effect of dietary fat on breast cancer survival among Caucasian and Japanese women in Hawaii
Nomura, A. M. Y., Marchand, L. L., Kolonel, L. N., & Hankin, J. H. (1991) · Breast Cancer Research and Treatment · doi:10.1007/bf02633546 · Cited by 71
Insulin Receptors in Breast Cancer
Belfiore, A., Frittitta, L., Costantino, A., Frasca, F., Pandini, G., Sciacca, L., Goldfine, I. D., & Vigneri, R. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb16235.x · Cited by 70
VATTEN, L. J., FOSS, O. P., & Kvinnsland, S. (1991) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(91)90234-5 · Cited by 57
Menon, R. K., & Sperling, M. A. (1996) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70344-3 · Cited by 57
An examination of obesity and breast cancer survival in post-menopausal women
Katoh, A. K., Watzlaf, V., & D'Amico, F. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.422 · Cited by 50
The influence of obesity on the disease-free survival in primary breast cancer.
Obermair, A., Kurz, C., Hanzal, E., et al. (1996) · PubMed · Cited by 48
den Tonkelaar, I., de Waard, F., Seidell, J. C., et al. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00665785 · Cited by 42
Body size and breast cancer prognosis: a statistical explanation of the discrepancies.
Suissa, S., Pollak, M., Spitzer, W. O., & Margolese, R. G. (1989) · PubMed · Cited by 41
Toropainen, E., Lipponen, P., & Syrjänen, K. J. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(94)00466-i · Cited by 36
Increased levels of glycoproteins containing mannose 6-phosphate in human breast carcinomas.
Sleat, D. E., Chen, T. L., Raska, K., Jr., & Lobel, P. (1995) · PubMed · Cited by 32
The insulin-like growth factors and breast cancer — revisited
Yee, D. (1998) · Breast Cancer Research and Treatment · doi:10.1023/a:1005938615798 · Cited by 32
Törnberg, S., & Carstensen, J. M. (1993) · European Journal of Cancer · doi:10.1016/0959-8049(93)90466-s · Cited by 30
Ho, G., Ji, C., Phang, B. H., Lee, K., Soo, K. C., & Ng, E.-H. (1998) · Annals of Surgical Oncology · doi:10.1007/bf02303501 · Cited by 30
Scheen, A. J., & Lefèbvre, P. J. (1996) · PubMed · Cited by 24
Obesity as prognostic factors in breast cancer
Kimura, M. (1990) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(90)90171-o · Cited by 21
Whitelaw, D. C., & Gilbey, S. G. (1998) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329803500501 · Cited by 18
Research works printed but not linked: 6
- 10.1002/ijc.2910490409 · doi:10.1002/ijc.2910490409
- 10.1038/bjc.1997.129 · doi:10.1038/bjc.1997.129
- 10.1002/(SICI)1096-9896(199712)183:4<412::AID-PATH944>3.0.CO;2-4 · doi:10.1002/(sici)1096-9896(199712)183:4<412::aid-path944>3.0.co;2-4
- 10.1007/BF00665970 · doi:10.1007/bf00665970
- 10.1177/030089169408000309 · doi:10.1177/030089169408000309
- 10.1016/0960-0760(90)90426-L · doi:10.1016/0960-0760(90)90426-l
Cited by
Insulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059
Physical activity and survival after breast cancer diagnosis
Holmes, M. D. (2005) · JAMA · doi:10.1001/jama.293.20.2479 · Cited by 1,772
Insulin-like growth factors and neoplasia
Pollak, M. N., Schernhammer, E. S., & Hankinson, S. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1387 · Cited by 1,463
Grundy, S. M. (2011) · Atlas of Atherosclerosis and Metabolic Syndrome · doi:10.1007/978-1-4419-5839-6_1 · Cited by 1,223
Chan, D. S. M., Vieira, A. R., Aune, D., Bandera, E. V., Greenwood, D. C., McTiernan, A., Navarro Rosenblatt, D., Thune, I., Vieira, R., & Norat, T. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu042 · Cited by 1,165
Metadata
- Authors
- Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M. E., Koo, J., Madarnas, Y., Hartwick, W., Hoffman, B., & Hood, N.
- Venue
- Journal of Clinical Oncology
- Published
- 2002-01-01
- Volume
- 20
- Issue
- 1
- Pages
- 42-51
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2099111137
- Cited by
- 981
- References
- 49
- FWCI
- 11.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.